EPO Patents = 1

Trademarks = 2

Forward Citations = 3

Loading Chart...

1 inventor (with patents filed for the assignee):

Russell Dahl (5 out of 14 patents)

5 patents: Sort by Forward Citations

1. 12144806 - Quinolines that modulate SERCA and their use for treating disease (2024-11-19),

2. 11992487 - Quinolines that modulate SERCA and their use for treating disease (2024-05-28),

3. 11890279 - Quinolines that modulate SERCA and their use for treating disease (2024-02-06),

4. 11827626 - Quinolines that modulate SERCA and their use for treating disease (2023-11-28),

5. 11730729 - Quinolines that modulate SERCA and their use for treating disease (2023-08-22),

Neurodon Corporation is a leading biotechnology company focused on developing innovative treatments for neurological disorders. With a team of dedicated scientists and researchers, we are committed to advancing the field of neuroscience through cutting-edge research and breakthrough discoveries. Our goal is to improve the lives of patients suffering from debilitating conditions such as Alzheimer's disease, Parkinson's disease, and epilepsy. Visit our website to learn more about our groundbreaking therapies and ongoing clinical trials.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

5 Patents

#3 in Crown Point, IN

#735 in Indiana

#51,545 in US

Crown Point, IN, United States of America

Neurodon Corporation

Forward Citations = 3

1 inventor:

Russell Dahl (5 out of 14 patents)

Please report any incorrect information to [email protected]

1 patent (EPO):

Please report any incorrect information to [email protected]